Heymanns J - Search Results

1

Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022.

Weide R, Thomalla J, van Roye C, Chakupurakal G, Heymanns J, Köppler H, Feiten S, Nickel JA, Schmidberger H, Theobald M, Lutz C. Weide R, et al. Among authors: heymanns j. GMS J Med Educ. 2022 Sep 15;39(4):Doc40. doi: 10.3205/zma001561. eCollection 2022. GMS J Med Educ. 2022. PMID: 36310886 Free PMC article.

2

Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF).

Weide R, Köppler H, Heymanns J, Pflüger KH, Havemann K. Weide R, et al. Among authors: heymanns j. Br J Haematol. 1992 Apr;80(4):557-9. doi: 10.1111/j.1365-2141.1992.tb04574.x. Br J Haematol. 1992. PMID: 1374635 No abstract available.

3

Successful treatment of neutropenia in T-LGL leukemia (T gamma-lymphocytosis) with granulocyte colony-stimulating factor.

Weide R, Heymanns J, Köppler H, Tiemann M, Huss B, Pflüger KH, Havemann K. Weide R, et al. Among authors: heymanns j. Ann Hematol. 1994 Sep;69(3):117-9. doi: 10.1007/BF01695691. Ann Hematol. 1994. PMID: 7522057

4

Storage of noncryopreserved periphered blood stem cells for transplantation.

Hechler G, Weide R, Heymanns J, Köppler H, Havemann K. Hechler G, et al. Among authors: heymanns j. Ann Hematol. 1996 May;72(5):303-6. doi: 10.1007/s002770050176. Ann Hematol. 1996. PMID: 8645742

5

Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenström's macroglobulinaemia.

Weide R, Heymanns J, Köppler H. Weide R, et al. Among authors: heymanns j. Leuk Lymphoma. 1999 Dec;36(1-2):203-6. doi: 10.3109/10428199909145966. Leuk Lymphoma. 1999. PMID: 10613467

6

The polyneuropathy associated with Waldenström's macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximab.

Weide R, Heymanns J, Köppler H. Weide R, et al. Among authors: heymanns j. Br J Haematol. 2000 Jun;109(4):838-41. doi: 10.1046/j.1365-2141.2000.02086.x. Br J Haematol. 2000. PMID: 10929038 Free article.

7

Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions.

Köppler H, Heymanns J, Weide R. Köppler H, et al. Among authors: heymanns j. Onkologie. 2001 Jun;24(3):283-5. doi: 10.1159/000055093. Onkologie. 2001. PMID: 11455223 Clinical Trial. English, German.

8

Bendamustine mitoxantrone and rituximab (BMR): a new effective regimen for refractory or relapsed indolent lymphomas.

Weide R, Heymanns J, Gores A, Köppler H. Weide R, et al. Among authors: heymanns j. Leuk Lymphoma. 2002 Feb;43(2):327-31. doi: 10.1080/10428190290006107. Leuk Lymphoma. 2002. PMID: 11999564 Clinical Trial.

9

Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy.

Weide R, Heymanns J, Pandorf A, Köppler H. Weide R, et al. Among authors: heymanns j. Lupus. 2003;12(10):779-82. doi: 10.1191/0961203303lu449cr. Lupus. 2003. PMID: 14596428

10

[Severe lead poisoning due to Ayurvedic indian plant medicine].

Weide R, Engelhart S, Färber H, Kaufmann F, Heymanns J, Köppler H. Weide R, et al. Among authors: heymanns j. Dtsch Med Wochenschr. 2003 Nov 14;128(46):2418-20. doi: 10.1055/s-2003-43590. Dtsch Med Wochenschr. 2003. PMID: 14614655 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters